FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab

NCT00383136 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

692

Enrollment

OTHER

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: tirofiban high-bolus dose regimen
DRUG: Abciximab

Sponsor

University of Bologna